急性运动功能缺陷的评估

Gallego J, Munoz R, Martinez-Vila E. Emergent cerebrovascular disease risk factor weighting: is transient ischemic attack an imminent threat? Cerebrovasc Dis. 2009;27(suppl 1):S88-S96.

• 摘要

Goldfrank LR, Flomenbaum NE, Lewin NA, et al, eds. Goldfrank's toxicologic emergencies 7th ed. New York, NY: McGraw-Hill Professional; 2002.

1.  Förster A, Griebe M, Wolf ME, et al. How to identify stroke mimics in patients eligible for intravenous thrombolysis? J Neurol. 2012;259:1347-1353.

• 摘要

2.  Nesnídal P, Stulík J, Barna M. Spinal cord concussion: a retrospective study of twenty-four patients [in Czech]. Acta Chir Orthop Traumatol Cech. 2012;79:150-155.

• 摘要

3.  Dimachkie MM, Barohn RJ. Guillain-Barré syndrome and variants. Neurol Clin. 2013;31:491-510.

• 全文
• 摘要

4.  Clinical Practice Guidelines and Protocols in British Columbia. Stroke and transient ischemic attack - acute and long-term management. April 2015. http://www2.gov.bc.ca (last accessed 22 August 2016).

• 全文

5.  Hacke W, Kaste M, Bluhmki E, et al. ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-1329.

• 全文
• 摘要

6.  Saver JL. Time is brain - quantified. Stroke. 2006;37:263-266.

• 全文
• 摘要

7.  Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke. 2005;36:1432-1438.

• 全文
• 摘要

8.  Rodrigues FB, Neves JB, Caldeira D, at al. Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis. BMJ. 2016;353:i1754.

• 全文
• 摘要

9.  Gajdos P, Chevret S, Toyka KV. Intravenous immunoglobulin for myasthenia gravis. Cochrane Database Syst Rev. 2012;(12):CD002277.

• 全文
• 摘要

10.  Le Quintrec JS, Le Quintrec JL. Drug-induced myopathies. Baillieres Clin Rheumatol. 1991;5:21-38.

• 摘要

11.  Luzzani A, Polati E, Dorizzi R, et al. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med. 2003;31(6):1737-1741.

• 摘要

12.  Schuetz P, Christ-Crain M, Müller B. Procalcitonin and other biomarkers for the assessment of disease severity and guidance of treatment in bacterial infections. 2008. http://www.advancesinsepsis.com (last accessed 22 August 2016).

• 全文

13.  Yealy DM, Fine MJ. Measurement of serum procalcitonin: a step closer to tailored care for respiratory infections? JAMA. 2009;302(10):1115-1116.

• 摘要

14.  Meisner M, Tschaikowsky K, Palmaers T, et al. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care. 1999;3(1):45-50.

• 全文
• 摘要

15.  Argov Z, Mastaglia FL. Drug-induced peripheral neuropathies. Br Med J. 1979;1:663-666.

• 全文
• 摘要

16.  National Institutes of Health. NIH stroke scale. November 2011. http://www.strokecenter.org (last accessed 22 August 2016).

• 全文

17.  Feldmann E, Broderick JP, Kernan WN, et al. Major risk factors for intracerebral hemorrhage in the young are modifiable. Stroke. 2005;36:1881-1885.

• 全文
• 摘要

18.  Brott T, Thalinger K, Hertzberg V. Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke. 1986;17:1078-1083.

• 全文
• 摘要

19.  Fazekas F, Niederkorn K, Ebner F, et al. Relevance of neuroimaging in the evaluation of cerebral ischemia. Cerebrovasc Dis. 2009;27(suppl 1):S1-S8.

• 摘要

20.  Marks MP. CT in ischemic stroke. Neuroimaging Clin N Am. 1998;8:515-523.

• 摘要

21.  Schramm P, Schellinger PD, Klotz E, et al. Comparison of perfusion computed tomography and computed tomography angiography source images with perfusion-weighted imaging and diffusion-weighted imaging in patients with acute stroke of less than 6 hours' duration. Stroke. 2004;35:1652-1658.

• 全文
• 摘要

22.  Gallego J, Munoz R, Martinez-Vila E. Emergent cerebrovascular disease risk factor weighting: is transient ischemic attack an imminent threat? Cerebrovasc Dis. 2009;27(suppl 1):S88-S96.

• 摘要

23.  Powers WJ, Rabinstein AA, Ackerson T, et al; American Heart Association Stroke Council. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018 Mar;49(3):e46-e110.

• 全文
• 摘要

24.  Schaefer PW, Romero JM, Grant PE, et al. Diffusion magnetic resonance imaging of acute ischemic stroke. Semin Roentgenol. 2002;37:219-229.

• 摘要

25.  Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med. 1994;120:897-902.

• 摘要

26.  Catanzaro JN, Meraj PM, Zheng S, et al. Electrocardiographic T-wave changes underlying acute cardiac and cerebral events. Am J Emerg Med. 2008;26:716-720.

• 摘要

27.  McCarron MO, Alberts MJ, McCarron P. A systematic review of Terson's syndrome: frequency and prognosis after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2004;75:491-493.

• 全文
• 摘要

28.  Clayman GL, Adams GL, Paugh DR, et al. Intracranial complications of paranasal sinusitis: a combined institutional review. Laryngoscope. 1991;101:234-239.

• 摘要

29.  Gallagher RM, Gross CW, Phillips CD. Suppurative intracranial complications of sinusitis. Laryngoscope. 1998;108:1635-1642.

• 摘要

30.  Rosenfeld EA, Rowley AH. Infectious intracranial complications of sinusitis, other than meningitis, in children: 12-year review. Clin Infect Dis. 1994;18:750-754.

• 摘要

31.  Younis RT, Anand VK, Davidson B. The role of computed tomography and magnetic resonance imaging in patients with sinusitis with complications. Laryngoscope. 2002;112:224-229.

• 摘要

32.  Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011 Feb;69(2):292-302.

• 摘要

33.  Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018 Feb;17(2):162-173.

• 摘要

34.  Freedman MS, Thompson EJ, Deisenhammer F, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol. 2005;62:865-870.

• 全文
• 摘要

35.  Winer JB. Treatment of Guillain-Barre syndrome. QJM. 2002;95:717-721.

• 全文
• 摘要

36.  Seneviratne U. Guillain-Barre syndrome. Postgrad Med J. 2000;76:774-782.

• 全文
• 摘要

37.  Winer JB. Guillain Barre syndrome. Mol Pathol. 2001;54:381-385.

• 全文
• 摘要

38.  Duna G, Calabrese LH. Primary angiitis of the central nervous system. In: Kalimo H, ed. Pathology and genetics, cerebrovascular diseases. Basel, Switzerland: ISN Neuropath Press; 2005:147-151.

39.  Calabrese LH. Primary angiitis of the central nervous system. In: Rheumatology. 4th ed. Hochberg M, Silman A, Smolen J, et al, eds. St. Louis, MO: Mosby; 2005.

40.  Aviv RI, Benseler SM, Silverman ED, et al. MR imaging and angiography of primary CNS vasculitis of childhood. AJNR Am J Neuroradiol. 2006;27:192-199.

• 全文
• 摘要

41.  Berman M, Feldman S, Alter M, et al. Acute transverse myelitis: incidence and etiologic considerations. Neurology. 1981;31:966-971.

• 摘要

42.  Murthy JM, Reddy JJ, Meena AK, et al. Acute transverse myelitis: MR characteristics. Neurol India. 1999;47:290-293.

• 全文
• 摘要

43.  Bayas A, Gold R. Diagnostic principles in myopathies. Fortschr Neurol Psychiatr. 2003;71:61-66.

• 摘要

44.  Amato AA, Barohn RJ. Idiopathic inflammatory myopathies. Neurol Clin. 1997;15:615-648.

• 摘要

45.  Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344-347.

• 摘要

46.  Lehmann-Horn F, Jurkat-Rott K, Rudel R, et al. Diagnostics and therapy of muscle channelopathies: guidelines of the Ulm Muscle Center. Acta Myol. 2008;27:98-113.

• 摘要

47.  Cherian A, Baheti NN, Kuruvilla A. Muscle channelopathies and electrophysiological approach. Ann Indian Acad Neurol. 2008;11:20-27.

• 全文

48.  Rakowicz W, Hanna M. Muscle ion channel diseases: advances in Clinical Neurosciences and Rehabilitation (ACNR). 2003;3:14-17.

• 全文

49.  Vassilopoulos D, Calabrese LH. Extrahepatic immunological complications of hepatitis C virus infection. AIDS. 2005;19(suppl 3):S123-S127.

• 摘要

50.  National Institute of Neurological Disorders and Stroke, NIH. Amyotrophic lateral sclerosis fact sheet. June 2013. http://www.ninds.nih.gov/ (last accessed 22 August 2016).

• 全文

51.  Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1994;124(suppl):96-107.

• 摘要

52.  Mitsumoto H, Chad DA, Pioro EP. Amyotrophic lateral sclerosis. In: Contemporary neurology series, 49. Philadelphia, PA: F.A. Davis Company; 1998.

53.  Harrington TM, Cohen MD, Bartleson JD, et al. Elevation of creatine kinase in amyotrophic lateral sclerosis: potential confusion with polymyositis. Arthritis Rheum. 1983;26:201-205.

• 摘要

54.  Dziewas R, Warnecke T, Schnabel M, et al. Neuroleptic-induced dysphagia: case report and literature review. Dysphagia. 2007;22:63-67.

• 摘要

55.  Goldfrank LR, Flomenbaum NE, Lewin NA, et al, eds. Goldfrank's toxicologic emergencies 7th ed. New York, NY: McGraw-Hill Professional; 2002.

56.  Potteiger JA, Carper MJ, Randall JC, et al. Changes in lower leg anterior compartment pressure before, during, and after creatine supplementation. J Athl Train. 2002;37:157-163.

• 全文
• 摘要

57.  Owen CA, Mubarak SJ, Hargens AR, et al. Intramuscular pressures with limb compression clarification of the pathogenesis of the drug-induced muscle-compartment syndrome. N Engl J Med. 1979;300:1169-1172.

• 摘要

58.  Howe FA, Opstad KS. 1H MR spectroscopy of brain tumours and masses. NMR Biomed. 2003;16:123-131.

• 摘要

59.  Usenius JP, Kauppinen RA, Vainio PA, et al. Quantitative metabolite patterns of human brain tumors: detection by 1H NMR spectroscopy in vivo and in vitro. J Comput Assist Tomogr. 1994;18:705-713.

• 摘要

60.  Hallmayer J, Faraco J, Lin L, et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet. 2009;41:708-711.

• 摘要

61.  Hersen M, Turner SM, Beidel DC, eds. Adult psychopathology and diagnosis. 5th ed. Wiley; 2007;380.